熱門資訊> 正文

Kodiak Sciences GAAP每股收益为-1.04美元

2026-04-01 04:49

Kodiak Sciences Inc.(KOD) 0

Kodiak Sciences press release (KOD): Q4 GAAP EPS of -$1.04 in-line.
Kodiak ended 2025 with $209.9 million of cash and cash equivalents. The firm believes that its current cash and cash equivalents will support its current and planned operations into 2027.

More on Kodiak Sciences

Kodiak Sciences: Shares Up On Positive Eye Disease Data - But I Remain On Sidelines
Kodiak Sciences Inc. (KOD) Presents at Angiogenesis, Exudation, and Degeneration 2026 - Slideshow
Kodiak Sciences: A Stellar Move
Kodiak climbs on late-stage trial win for diabetic retinopathy therapy
Seeking Alpha’s Quant Rating on Kodiak Sciences

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。